![Julio Castro-Palomino Laria](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julio Castro-Palomino Laria
Founder at Origo Biopharma SL
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Maria do Carme Pampín Casal | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | 7 years |
Ramon Bosser | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Andrea Sáez | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Clara Campas-Moya | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Yolanda Falcón | F | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Spain | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Julio Castro-Palomino Laria
- Personal Network